Imthera Medical

LivaNova closed the $225 million acquisition of ImThera Medical, which makes the Aura6000 implantable hypoglossal nerve stimulator for sleep apnea. LivaNova paid $78 million upfront, with $147 million due on milestones.

Livanova Plc entered into an agreement to acquire the remaining outstanding interests in Imthera Medical, Inc. for up to approximately $225 million, with $78 million upfront and the balance in milestone payments.